Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis
{{output}}
Background: High efficacy therapies (HET) play a crucial role in multiple sclerosis (MS) management. HET discontinuation/de-escalation is a critical decision, especially in different age groups, due to potential changes in relaps... ...
